Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma.
about
Synthesis and evaluation of alendronate-modified gelatin biopolymer as a novel osteotropic nanocarrier for gene therapy.Tectorigenin inhibits osteosarcoma cell migration through downregulation of matrix metalloproteinases in vitro.Nano-confinement-driven enhanced magnetic relaxivity of SPIONs for targeted tumor bioimaging.Cisplatin-directed coordination-crosslinking nanogels with thermo/pH-sensitive triblock polymers: improvement on chemotherapic efficacy via sustained release and drug retention.
P2860
Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Development of Alendronate-con ...... of Cisplatin in Osteosarcoma.
@ast
Development of Alendronate-con ...... of Cisplatin in Osteosarcoma.
@en
type
label
Development of Alendronate-con ...... of Cisplatin in Osteosarcoma.
@ast
Development of Alendronate-con ...... of Cisplatin in Osteosarcoma.
@en
prefLabel
Development of Alendronate-con ...... of Cisplatin in Osteosarcoma.
@ast
Development of Alendronate-con ...... of Cisplatin in Osteosarcoma.
@en
P2093
P2860
P356
P1433
P1476
Development of Alendronate-con ...... of Cisplatin in Osteosarcoma.
@en
P2093
Dong-sheng Zhou
Peng Zhang
Qing-hu Li
Rong-Jie Feng
Yong-hui Wang
P2860
P2888
P356
10.1038/SREP17387
P407
P577
2015-12-01T00:00:00Z